Plasmodium yoelii
WikiDoc Resources for Plasmodium yoelii |
Articles |
---|
Most recent articles on Plasmodium yoelii Most cited articles on Plasmodium yoelii |
Media |
Powerpoint slides on Plasmodium yoelii |
Evidence Based Medicine |
Cochrane Collaboration on Plasmodium yoelii |
Clinical Trials |
Ongoing Trials on Plasmodium yoelii at Clinical Trials.gov Trial results on Plasmodium yoelii Clinical Trials on Plasmodium yoelii at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Plasmodium yoelii NICE Guidance on Plasmodium yoelii
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Plasmodium yoelii Discussion groups on Plasmodium yoelii Patient Handouts on Plasmodium yoelii Directions to Hospitals Treating Plasmodium yoelii Risk calculators and risk factors for Plasmodium yoelii
|
Healthcare Provider Resources |
Causes & Risk Factors for Plasmodium yoelii |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Plasmodium achiotense is a parasite of the genus Plasmodium subgenus Vinckeia.
Like all Plasmodium species P. yoelii has both vertebrate and insect hosts. The vertebrate hosts for this parasite are mammals.
Plasmodium yoelii | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scientific classification | ||||||||||||||
| ||||||||||||||
Binomial name | ||||||||||||||
Plasmodium yoelii |
Description
This species was described in 1968 by Landau, Michel and Adam.
Geographical occurrence
Clinical features and host pathology
This is a species that infects rodents.
Notes
Its most notable feature is that it is used in the laboratory to infect mice, as a model of human malaria, particularly with respect to the immune response.
It is advantageous to have a whole-animal model of malaria because often it is difficult to know which factors to study in vitro, particularly in a complex system like the immune system. Moreover, for many experiments it is not ethical or practical to use humans.
One of the special things about this particular model is that is has two strains with vastly different pathogenicity. These are generally referred to as the "lethal" and "non-lethal" strains of the species. Comparison of these two strains can be used to deduce which factors may contribute to more serious malaria infections in humans.